Related Experiment Video
Updated: Jun 14, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation
M Ehrenschwender1, D Siegmund, A Wicovsky
1Department of Internal Medicine II, University Hospital Würzburg, Germany.
Abstract:
Constitutively active PI3K catalytic subunit alpha (PIK3CA) interfered with apoptosis induction downstream of death receptor-signaling complex formation allowing robust caspase-8 activation without triggering the execution steps of apoptosis. In mutant PIK3CA-expressing cells, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and CD95L stimulated nuclear factor kappaB (NFkappaB) activation, invasion, and transition to an amoeboid-like morphology. NFkappaB activation and adoption of amoeboid shape were inhibited by caspase-8 knockdown or FLIP-S expression, but only the cell morphology alterations required caspase-8 activity. Furthermore, we identified caspase-8-mediated, caspase-3-independent cleavage of the protein kinase rho-associated, coiled-coil containing protein kinase 1 as a novel mechanism for acquiring amoeboid shape and enhanced invasiveness in response to TRAIL and CD95L. Taken together, we provide evidence that mutated PIK3CA converts the 'tumor surveillance' activity of cancer cell-expressed death receptors and caspase-8 toward tumor promotion.
Insights
Mutant PIK3CA promotes tumor growth by hijacking cell death pathways. This activates caspase-8 without apoptosis, driving invasion and amoeboid shape changes, converting tumor surveillance into promotion.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Signaling Pathways
Background:
- Constitutively active PI3K catalytic subunit alpha (PIK3CA) mutations are common in cancer.
- PIK3CA signaling can impact apoptosis and cell behavior.
- Death receptor signaling pathways, including TRAIL and CD95L, are involved in apoptosis and immune surveillance.
Purpose of the Study:
- To investigate how constitutively active PIK3CA affects apoptosis induction and downstream signaling.
- To elucidate the role of caspase-8 in PIK3CA-mediated cellular changes.
- To identify novel mechanisms by which PIK3CA promotes tumor progression.
Main Methods:
- Utilized cells expressing mutant PIK3CA.
- Stimulated cells with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and CD95L.
- Assessed apoptosis induction, caspase-8 activation, nuclear factor kappaB (NFkappaB) activation, cell morphology, and invasion.
- Performed caspase-8 knockdown and FLIP-S expression experiments.
- Investigated cleavage of rho-associated, coiled-coil containing protein kinase 1 (ROCK1).
Main Results:
- Mutant PIK3CA allowed caspase-8 activation without apoptosis execution.
- TRAIL and CD95L induced NFkappaB activation, invasion, and amoeboid morphology in mutant PIK3CA cells.
- NFkappaB activation and amoeboid shape changes were inhibited by caspase-8 knockdown or FLIP-S.
- Cell morphology changes required caspase-8 activity, but not caspase-3.
- Identified caspase-8-mediated, caspase-3-independent cleavage of ROCK1, promoting amoeboid shape and invasiveness.
Conclusions:
- Mutated PIK3CA redirects death receptor signaling from tumor surveillance to tumor promotion.
- Caspase-8 activation, independent of apoptosis, drives cancer cell invasion and morphological changes.
- Caspase-8-mediated ROCK1 cleavage is a novel mechanism for enhanced cancer cell invasiveness.
Related Concept Videos
Caspases
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

